Hepatic arterial infusion chemotherapy (HAIC) combined with Regorafenib and PD-1 inhibitors versus Regorafenib combined with PD-1 inhibitors for second-line treatment Hepatocellular carcinoma (HCC)
作者全名："You, N.; Peng, X.; Li, J.; Wang, L.; Wu, K.; Zheng, L.; Li, D.; Chen, Z.; Zhang, H.; Huang, P.; Wang, Y.; Liao, R.; Li, Q.; Guo, P.; Wang, W."
作者地址："[You, N.; Peng, X.; Li, J.; Wang, L.; Wu, K.; Zheng, L.] Army Med Univ, Dept Hepatobiliary Surg, Affiliated Hosp 2, Chongqing, Peoples R China; [Li, D.; Wang, Y.] Chongqing Univ, Dept Hepatobiliary, Canc Hosp, Pancreat Tumor Ctr, Chongqing, Peoples R China; [Chen, Z.; Zhang, H.] Third Mil Med Univ, Dept Hepatobiliary Surg, Affiliated Hosp 1, Army Mil Univ, Chongqing, Peoples R China; [Huang, P.; Liao, R.] Chongqing Med Univ, Dept Hepatobiliary Surg, Affiliated Hosp 1, Chongqing, Peoples R China; [Li, Q.] Chongqing Univ, Dept Intervent Radiol, Canc Hosp, Chongqing, Peoples R China; [Guo, P.] Chongqing Med Univ, Dept Hepatobiliary Surg, Affiliated Hosp 3, Chongqing, Peoples R China; [Wang, W.] Peoples Hosp Tongliang Dist Chongqing city, Dept Hepatobiliary Surg, Chongqing, Peoples R China"
通信作者：
来源：ANNALS OF ONCOLOGY
ESI学科分类：CLINICAL MEDICINE
WOS号：WOS:001087480201308
JCR分区：Q1
影响因子：50.5
年份：2023
卷号：34
期号：
开始页：S605
结束页：S605
文献类型：Meeting Abstract
关键词：
摘要：
基金机构：
基金资助正文：
